Act1 Adaptor Protein Is an Immediate and Essential Signaling Component of Interleukin-17 Receptor
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17, the founding member of the IL-17 cytokine family, is the hallmark of a novel subset of CD4+ T cells that is regulated by TGFbeta, IL-6, and IL-23. IL-17 plays an important role in promoting tissue inflammation in host defense against infection and in autoimmune diseases. Although IL-17 has been reported to regulate the expression of proinflammatory cytokines, chemokines, and matrix metalloproteinases, the signaling mechanism of IL-17 receptor has not been understood. An earlier study found that IL-17 activates NF-kappaB and MAPK pathways and requires TRAF6 to induce IL-6. However, it is unknown what molecule(s) directly associates with IL-17 receptor to initiate the signaling. We demonstrate here that IL-17 receptor family shares sequence homology in their intracellular region with Toll-IL-1 receptor (TIR) domains and with Act1, a novel adaptor previously reported as an NF-kappaB activator. MyD88 and IRAK4, downstream signaling components of TIR, are not required for IL-17 signaling. On the other hand, Act1 and IL-17 receptor directly associate likely via homotypic interaction. Deficiency of Act1 in fibroblast abrogates IL-17-induced cytokine and chemokine expression, as well as the induction of C/EBPbeta, C/EBPdelta, and IkappaBzeta. Also, absence of Act1 results in a selective defect in IL-17-induced activation of NF-kappaB pathway. These results thus indicate Act1 as a membrane-proximal adaptor of IL-17 receptor with an essential role in induction of inflammatory genes. Our study not only for the first time reveals an immediate signaling mechanism downstream of an IL-17 family receptor but also has implications in therapeutic treatment of various immune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Act1 is best understood as a nonredundant activator of IL-17RA-dependent signals”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chang et al., 2006
In the citing paper
“TRAF6 also promotes activation of MAPK/AP1 pathways and the C/EBPβ and δ transcription factors”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Chang et al., 2006
Citations
Cites
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Self-citationKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
Toy, D., Kugler, D., Wolfson, M., Bos, T. V., Gurgel, J., Derry, J., Tocker, J., & Peschon, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.36 · Cited by 570
Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells
Dong, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1807 · Cited by 487
Self-citationKao, C.-Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., & Wu, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3482 · Cited by 424
Shalom-Barak, T., Quach, J., & Lotz, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27467 · Cited by 388
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
Cited by
Items 301–366 of 366
Neonatal Pulmonary Host Defense
Empey, K. M., & Kolls, J. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3479-7.10159-4 · Cited by 4
Effect of IL-17 on osteoclast differentiation of RAW264 cells
Sumikura, S., Inoue, H., Nishikawa, Y., & Matsumoto, N. (2012) · Journal of Osaka Dental University · doi:10.18905/jodu.46.1_11 · Cited by 3
Interleukin-22: A Bridge Between Epithelial Innate Host Defense and Immune Cells
Wang, X., & Ouyang, W. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_6 · Cited by 2
“Act1 is an important adaptor molecule recruited to the receptor of IL-17 and is essential for the function of IL-17 (Chang et al. 2006 ; Qian et al. 2007 ).”
BackgroundChen, C., Feng, J., Amu, J., Wen, Z., Tan, Y., Xu, Y., Pu, X., Lu, M., Song, X., Xu, L., et al. (2025) · Veterinary Research · doi:10.1186/s13567-025-01649-y · Cited by 2
“Ligation of IL-17 to its cognate receptor (IL-17R) triggers recruitment of the adaptor ACT1 to the receptor’s SEFIR domain, facilitating TRAF6-dependent K63-linked polyubiquitination that initiates downstream NF-κB and MAPK signaling [59].”
Li, Y., Xu, Z., Zhang, X., Zhang, Z., Ji, C., Guo, X., Zhang, J., Feng, P., Mao, R., Liu, Z., et al. (2026) · Inflammation Research · doi:10.1007/s00011-025-02159-5 · Cited by 2
“It activates NF-κB/MAPKs through SEFIR– SEFIR-mediated receptor binding and subsequent TRAF engagement [ 35, 36].”
Feng, R., Huang, H., Ma, Q., Gao, W., Chen, X., Yan, X., Wang, F., Zhang, Q., Cao, Y., Zhang, H., et al. (2026) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-026-01401-2 · Cited by 2
“…binding to the IL-17RA receptor on target cell surfaces, IL-17A recruits ACT1 and TRAF6, subsequently activating downstream MAPK and NF-κB signaling pathways, resulting in massive release of proinflammatory factors, which exacerbates inflammatory responses and was confirmed in this study [35, 36].”
The tissue-specific regulation of immunobiology by IL-17 signaling
Li, Y., Vyas, S., Dráber, P., Bechara, R., & Gaffen, S. L. (2026) · Science Immunology · doi:10.1126/sciimmunol.adq6406 · Cited by 2
Targeting interleukin-17 in the lungs
Ivanov, S., & Lindén, A. (2010) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000320813 · Cited by 2
Verdier, J., & Ruemmele, F. M. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.829471 · Cited by 2
“Interestingly, the intracytoplasmic region of each IL-17 receptor subunits contains a domain homologous to the Toll/IL-1R (TIR) domain of TLRs and IL-1R, known as SEFIR (similar expression to fibroblast growth factor genes and IL17R) domain [63].”
BackgroundNosaka, K., Inoue, H., Hirano, S.-I., Uchihashi, K., & Nishikawa, Y. (2014) · Journal of Osaka Dental University · doi:10.18905/jodu.48.2_117 · Cited by 3
“It has a long cytoplasmic tail with approximately 500 amino acids not found in any other cytokine receptor family, suggesting that they belong to a unique cytokine receptor family.(35) Members of the IL-17 family are also homodimeric and have been shown to bind and signal through both homodimeric and heteromeric count…”
BackgroundLi, D., Bechara, R., Ramani, K., Jawale, C. V., Li, Y., Kolls, J. K., Gaffen, S. L., & Biswas, P. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.425972 · Cited by 2
“There was no difference in the expression of Il6, Nfkbiz or Lcn2 in kidney at baseline (Fig 4D-F).”
BackgroundInfluentialHayashi, K., Sugisawa, R., Saito, T., Matsui, T., Taniguchi, Y., Batanova, T. A., Yanai, T., Matsumoto, J., KITOH, K., & Takashima, Y. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008685 · Cited by 1
“IL-17 is an inflammatory cytokine, and intracellular signaling by it does not require signaling molecules like MyD88 and IL-1 receptorassociated kinase 4, which are essential for IL-1β signaling, while another molecule, ACT1, functions as an adapter for IL-17 receptors [45].”
BackgroundRamachandran, R., Manan, A., Kim, E., & Choi, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148092 · Cited by 1
Majeed, S. T., Huss, N. P., Bradford, S. M., & Jondle, C. N. (2025) · Journal of Virology · doi:10.1128/jvi.01842-25 · Cited by 1
“The signaling events downstream of the IL-17RA– IL-17RC receptor utilize the adapter Act1 to recruit and ubiquitinate TRAF6, leading to the activation of the NF-kB and MAPK pathways (27–29).”
IL-17 in ocular fibrosis: From molecular mechanisms to precision therapeutics
Li, H., & Zhao, Y.-E. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111003 · Cited by 1
Liu, M., Xie, W., Wu, Z., Wu, W., Li, G., Wang, L., Jing, Y., & Zhang, W. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116770 · Cited by 1
Vunakizumab for IL-17A–Mediated Diseases: A Review in Psoriasis and Spondyloarthritis
Yan, H., Chen, Y., Song, Y., Yan, M., & Yan, K. (2026) · Biologics · doi:10.2147/btt.s500475 · Cited by 1
“11,14,37,38 In addition to transcriptional activation, IL-17 signaling can enhance inflammatory responses through stabilization of pro-inflammatory transcripts.”
Targeting Interleukin-17A – An Orchestrator of Neutrophil Mobilisation in the Lungs
Lindén, A. (2010) · The Open Conference Proceedings Journal · doi:10.2174/22102892010010100021 · Cited by 1
The Roles of Interleukin-17 and T Helper 17 Cells in Intestinal Barrier Function
Trusevych, E., Mortimer, L. M., & Chadee, K. (2012) · InTech eBooks · doi:10.5772/29441 · Cited by 1
“Classical Th1 and Th2 cytokines activate JAK/STAT signaling, however IL-17A and IL-17F mediate signaling through nuclear factor (NF)-κB, NF-κB activator 1 (Act1) and tumor necrosis factor (TNF) receptor associated factor 6 (TRAF6) (Chang et al., 2006; Schwandner et al., 2000; Yao et al., 1995b).”
BackgroundFunctions of IL-17-Producing γ δ T Cells
Shibata, K., & Yoshikai, Y. (2014) · The Open Immunology Journal · doi:10.2174/1874226200902010151 · Cited by 1
“IL-17RA mRNA expression was detected in the spleen, lung, liver and kidney and various cell lines such as fibroblasts, epithelial cells, endothelial cells, myeloid cells and T cells [16].”
InfluentialTherapeutic targets in psoriatic arthritis
Orr, C. K., & Veale, D. J. (2015) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.15.52 · Cited by 1
Interleukin-25 induces allergic inflammation
Kouzaki, H., & Shimizu, T. (2012) · 耳鼻咽喉科免疫アレルギー · doi:10.5648/jjiao.30.237 · Cited by 1
Targeting the IL-17/IL-23 Axis in Chronic Inflammatory Immune-Mediated Diseases
Tsoukas, A., Goodyear, C. S., & McInnes, I. B. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00028-x · Cited by 4
Manoochehri, H., Gheitasi, R., Pourjafar, M., Ahmadieh-Yazdi, A., Sheykhhasan, M., & Amini, R. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101041 · Cited by 1
The role of IL-27 and IL-35 in inflammatory diseases.
Cai, B. (2008) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Lai, Y., & Dong, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10014-1 · Cited by 1
Self-citationStructure and IL-17 Receptor Signaling
Tsang, M., & Gaffen, S. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_9
IL-17F, a target for anti-cytokine therapy
Maitra, A., & Gaffen, S. L. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.4.453
Furlong, S. J. (2012) · Library and Archives Canada (Government of Canada)
FEEDBACK INHIBITION OF IL-17 RECEPTOR SIGNAL TRANSDUCTION
Garg, A. V. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Regulation of mRNA Stability in Chemokine Gene Expression
Hartupee, J. C. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Effects of Interleukin-17 on Endothelial Nitric Oxide Synthase and Transplant Arteriosclerosis
Liu, C.-Y. (2014) · Summit (Simon Fraser University)
Signal Transduction and TH17 Cell Differentiation
Yang, X., O’Shea, J. J., Ghoreschi, K., & Laurence, A. D. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_8 · Cited by 1
Singh, S. (2011) · Spiral (Imperial College London) · doi:10.25560/9605
Chu, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-28040-0_1
Diseases Caused by Genetic or Congenital Defects in the Immune System or Skin Immune System
Gutierrez, A., Pittelkow, M. R., Xi, L., Huang, X., & Rai, S. (2016) · Springer eBooks · doi:10.1007/978-94-024-0902-4_11
FUNCTIONAL REGULATION OF INTERLEUKIN-17 RECEPTOR SIGNALING
Cruz, J. A. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Culpepper, C. D. (2018) · Digital Archive @ GSU · doi:10.57709/13394582
Genetic basis of chronic mucocutaneous candidiasis disease in humans
Lévy, R. (2017) · theses.fr (ABES) · doi:10.70675/fbe0154ez44e5z43ccza33azb697756b8b48
The FYN-TRAF3IP2 gene fusion drives oncogenic NF-κB signaling in peripheral T cell lymphoma
Kim, C. S. (2020) · doi:10.7916/d8-5w9r-w324 · Cited by 1
Papel de la interleuquina-17 en procesos inflamatorios y patologías pulmonares
Losada, P. X., Cortés, J. S., Narváez, C. F., & Lastra, G. (2021) · Revista Médicas UIS · doi:10.18273/revmed.v34n1-2021006
Gaffen, S. L. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13199957.14542080
Gaffen, S. L., & Amatya, N. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732887195.793546043
Moser, M. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1168396.630574
(2022) · Science China Life Sciences · doi:10.1007/s11427-022-2101-x
“They were the first to find Act1 as an adaptor for the signaling of IL-17 family cytokines (Chang et al., 2006).”
BackgroundThe roles of MCPyV early region in IL-17A-mediated inflammation and autophagy
Miao, J. (2021) · theses.fr (ABES) · doi:10.70675/0ed263f9za522z491ezb888z3d6d2826cd2b
Revisiting the Roles of IL-17 in Colorectal Cancer
Cardoso, L. V., Zonaro, G. G., da Silva, B. N., Frederico, G., Barbieri, V., de, L. M. V., Pinheiro, S. L., Leal, R. F., & Degasperi, G. R. (2022) · International Journal of Science and Research (IJSR) · doi:10.21275/sr221112020219
Lai, Y., & Dong, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00090-9
Self-citationTHE DISTINCT AND AGGRESSIVE PATHOGENESIS OF ARTHRITIS IN CHILDREN WITH DOWN SYNDROME
Foo, S. (2023) · Trinity's Access to Research Output (TARA) (Trinity College Dublin)
Mathematical Modeling of the role of IL-23/Th17 in Asthma Pathogenesis
Kirenga, B. K. N., Kitayimbwa, J. M., & Mugisha, J. (2025) · Bulletin of Mathematical Biology · doi:10.1007/s11538-025-01567-2
“Several efforts to develop effective new therapies by modulating the Th1-Th2 cytokine balance (Park and Lee 2010) have yielded limited success in many clinical trials (Chang et al. 2006; Nakae et al. 2002) due to the development of severe asthma.”
Flavonoids as Potential Cardioprotective Agents against Myocarditis
Liu, J., Nie, N., Shi, Y., & Shen, Y. (2026) · The Natural Products Journal · doi:10.2174/0122103155417572251129045512
L’interleukine-17A induit un remodelage lipidique dans les cellules dendritiques humaines
Salvatore, G. (2012) · theses.fr (ABES) · doi:10.70675/6e34ef46zf0efz42c6zb690z3b934021dc1b
Carter, K. (2025) · Gutenberg Open Science · doi:10.25358/openscience-12332
TRAF3IP2 (Act1/CIKS) variants: A domain to phenotype framework and therapeutic implications
Alt, E. U., & Izadpanah, R. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.08.003
Fibroblast-Expressed IL-17D in Skin Inflammation and Cutaneous Wound Healing
Wang, L. (2026) · eScholarship (California Digital Library)
Targeting the IL-17A Cytokine Interface: Structural Insights and Small-Molecule Modulators
Kim, G. U., Lee, A., Lee, S., Jeon, B., Park, H., Kang, T., & Choo, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01296
Self-citationSerum NF-κB p105 and IL-17 in psoriasis: associations with disease status and severity
Caf, N., Mısırlıoglu, N. F., Dümür, Ş., Biltekin, B., Yavuz, G. Ö., Kırsoy, E. M., & Uzun, H. (2026) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2026.2748320
Yang, J., Luo, J., Zhou, Q., Chai, X., Wang, X., Li, J., Wang, M., Gu, X., Chang, X., Li, S., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120992
Osta, B. (2014) · theses.fr (ABES) · doi:10.70675/5a01b6a3z54bez472bzb376z221e31f28914 · Cited by 2
Metadata
- Authors
- Chang, S. H., Park, H., & Dong, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Dong, Chen
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 281
- Issue
- 47
- Pages
- 35603-35607
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W221516563
- Cited by
- 356
- References
- 17
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 8 · 2023: 16 · 2022: 16 · 2021: 19 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 17 · 2016: 14 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 23
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5082 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- interleukin-17 receptor, IL-17 signaling, NF-κB activation, C/EBPβ, C/EBPδ, chemokine expression, fibroblasts, inflammatory gene expression
- MeSH terms
- Animals, Humans, Inflammation, Mice, Inbred C57BL, Nuclear Proteins, Phylogeny, Protein Binding, Transcription, Genetic, Signal Transduction, CD4-Positive T-Lymphocytes, Protein Structure, Tertiary, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.